Market News

EPS for Nexeo Solutions, Inc. (NXEO) Expected At $0.21

Analysts expect Nexeo Solutions, Inc. (NASDAQ:NXEO) to report $0.21 EPS on December, 5.They anticipate $0.03 EPS change or 16.67 % from last quarter’s $0.18 EPS. NXEO’s profit would be $18.84 million giving it 11.92 P/E if the $0.21 EPS is correct. After having $0.19 EPS previously, Nexeo Solutions, Inc.’s analysts see 10.53 % EPS growth. The stock decreased 0.69% or $0.07 during the last trading session, reaching $10.01. About 343,900 shares traded. Nexeo Solutions, Inc. (NASDAQ:NXEO) has risen 40.87% since November 9, 2017 and is uptrending. It has outperformed by 25.25% the S&P500.

Nexeo Solutions, Inc. operates as a chemical and plastic products distributor in North America, Europe, the Middle East, Africa, and Asia. The company has market cap of $898.24 million. The firm operates through Chemicals, Plastics, and Environmental Services divisions. It has a 13.26 P/E ratio. It provides approximately 22,000 products used in various industries, including household, industrial and institutional, lubricants, architectural coatings, adhesives, sealants, elastomers, automotive, healthcare, personal care, gas and oil, and construction.

More notable recent Nexeo Solutions, Inc. (NASDAQ:NXEO) news were published by: Nasdaq.com which released: “Nexeo Solutions Awarded Silver Rating by EcoVadis” on October 22, 2018, also Nasdaq.com with their article: “Factors of Influence in 2018, Key Indicators and Opportunity within Apptio, Adamas Pharmaceuticals, NEXEO …” published on November 08, 2018, Globenewswire.com published: “Nexeo Solutions Named Authorized Distributor of Evonik Acrylic-Based Medical Products” on October 24, 2018. More interesting news about Nexeo Solutions, Inc. (NASDAQ:NXEO) were released by: Benzinga.com and their article: “75 Biggest Movers From Yesterday” published on November 07, 2018 as well as Benzinga.com‘s news article titled: “60 Stocks Moving In Tuesday’s Mid-Day Session” with publication date: November 06, 2018.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*